Hydroxychloroquine's Probable Protective Effect in Liver injury among the COVID-19 Patients.
作者信息
Sima Ali Reza
机构信息
Digestive Disease Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
出版信息
Middle East J Dig Dis. 2021 Jan;13(1):80-81. doi: 10.34172/mejdd.2021.209. Epub 2021 Mar 2.
Abstract
摘要
相似文献
1
Hydroxychloroquine's Probable Protective Effect in Liver injury among the COVID-19 Patients.
Middle East J Dig Dis. 2021 Jan;13(1):80-81. doi: 10.34172/mejdd.2021.209. Epub 2021 Mar 2.
2
A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2.
Front Med (Lausanne). 2020 Aug 13;7:490. doi: 10.3389/fmed.2020.00490. eCollection 2020.
3
Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study.
J Cardiovasc Pharmacol Ther. 2015 Mar;20(2):174-80. doi: 10.1177/1074248414546324. Epub 2014 Aug 14.
4
Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters.
Pharmaceutics. 2020 Sep 25;12(10):919. doi: 10.3390/pharmaceutics12100919.
5
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.
Lupus. 1996 Jun;5 Suppl 1:S11-5.
6
Hepatotropic Properties of SARS-CoV-2-Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic.
J Clin Med. 2021 Feb 9;10(4):672. doi: 10.3390/jcm10040672.
7
Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity.
Curr Pharm Des. 2004;10(21):2643-8. doi: 10.2174/1381612043383791.
8
The role of hydroxychloroquine in catastrophic antiphospholipid syndrome case: Series of two case reports and review of literature.
SAGE Open Med Case Rep. 2018 Jun 26;6:2050313X18782808. doi: 10.1177/2050313X18782808. eCollection 2018.
9
Pustular DRESS Syndrome Secondary to Hydroxychloroquine With EBV Reactivation.
J Drugs Dermatol. 2019 Feb 1;18(2):207-209.
10
A meta-analysis of the impact of COVID-19 on liver dysfunction.
Eur J Med Res. 2020 Nov 4;25(1):54. doi: 10.1186/s40001-020-00454-x.
引用本文的文献
1
Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes.
Front Pharmacol. 2022 Sep 15;13:972397. doi: 10.3389/fphar.2022.972397. eCollection 2022.
本文引用的文献
1
Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study.
Front Med (Lausanne). 2020 Jun 23;7:347. doi: 10.3389/fmed.2020.00347. eCollection 2020.
2
Predictor of poor prognosis of COVID-19 patients - liver injury.
Expert Rev Gastroenterol Hepatol. 2020 Oct;14(10):873-876. doi: 10.1080/17474124.2020.1793670. Epub 2020 Jul 30.
3
Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
Gut. 2021 Apr;70(4):733-742. doi: 10.1136/gutjnl-2020-321726. Epub 2020 Jul 8.
4
COVID-19 and liver injury: a meta-analysis.
Eur J Gastroenterol Hepatol. 2021 Jul 1;33(7):990-995. doi: 10.1097/MEG.0000000000001817.
5
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.
Aliment Pharmacol Ther. 2020 Aug;52(4):584-599. doi: 10.1111/apt.15916. Epub 2020 Jul 8.
6
Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
Hepatol Int. 2020 Sep;14(5):711-722. doi: 10.1007/s12072-020-10071-9. Epub 2020 Jul 4.
7
COVID-19 and the liver: little cause for concern.
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):529-530. doi: 10.1016/S2468-1253(20)30084-4. Epub 2020 Mar 20.
8
Chloroquine ameliorates carbon tetrachloride-induced acute liver injury in mice via the concomitant inhibition of inflammation and induction of apoptosis.
Cell Death Dis. 2018 Nov 26;9(12):1164. doi: 10.1038/s41419-018-1136-2.
9
Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phase.
Cell Death Dis. 2013 Jun 27;4(6):e694. doi: 10.1038/cddis.2013.225.
10
Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury.
Am J Pathol. 2010 Mar;176(3):1181-92. doi: 10.2353/ajpath.2010.090594. Epub 2010 Jan 14.
Zotero 插件